Clinical Trial Update: Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer

View source ↗

Summary

This clinical trial update describes an epidemiologic study examining KRAS mutations in Brazilian patients with advanced or metastatic non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Non Small Cell Lung Cancer | Status: COMPLETED